chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea; tiredness; swollen lymph node in armpit; aching joints; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 16:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and insulin resistance. The patient received unspecified blood pressure medicine and allergy medicine within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 16:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation and also had unspecified allergies to 17 different things (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021, the patient experienced nausea, tiredness, swollen lymph node in armpit and aching joints. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/ department or urgent care. The clinical outcomes of the events nausea and tiredness were recovered on 01Apr2021 after the duration of 1 day; while that of swollen lymph node in armpit and aching joints were recovered on unknown date in Apr2021 (reported as for about a week after).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: updated relevant medical history.
Site of injection swelled up and red.  Pharmacist recommended ice and tylenol for pain since patient can not take ibuprofen or other nsaids due to kidney insufficiency.
Fatigue several hours later and continuing for 3 days. Body aches for 3 days following. Nausea continuing currently. Arm pain at injection site continuing.
Vaccination area started to feel tender again this afternoon and tonight a welt has appeared where my shit was. About an inch wide and 5 inches long, easier, tender and warm, doesn?t itch.
Onset rash - Saturday 10-6-07. Rec'd vaccine (HPV #2) on 10-3-07. Rash now over arms, legs, feet, some on back - itching on same day. Was to be seen by clinician. Also - end of initial HSV infection - on Valtrex.
Pfizer 2/25/21, 3/25/21. Positive on 2/8/22
pt recv vax 1145AM to rt deltoid;mom states that arms was a blotchy redness on 18JUN96 & noticed swelling to rt arm 19JUN96;vax given 17JUN96 site to rt arm approx 1 3/4" x 2" in size w/redness noted;site tender to touch;
Rash; This spontaneous case was reported by a nurse and describes the occurrence of RASH (Rash) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.  Rash started 1 week after the vaccine and spread on the arm. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
kind of difficulty swallowing or numb; numb is associated with difficulty in swallowing; having some tingling in her mouth; soring in the throat; pain moving up radiating up to the ear; tingling thumb; This is a spontaneous report from a contactable pharmacist. A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 42-years-old, via an unspecified route of administration, administered in Arm Left on 25Sep2021 (Batch/Lot Number: FC3183; Expiration Date: Oct2021) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient experienced having some tingling in her mouth kind of difficulty swallowing or numb, numb was associated with difficulty in swallowing of but an increased hard time swallowing so they gave the patient some Benadryl 25 mg as treatment. The patient had difficulty in swallowing, some soring in the throat, tingling thumb and pain moving up radiating up to the ear. The events occurred on 25Sep2021. Her second dose was scheduled on 16Oct2021. The outcome of the events was not recovered.
Received ZOSTAVAX on 11-22-2013. Seen in Dr's office 11-25-2013 for (R) arm swelling, itchy, "there is erythematous area extending in circle around injection site size of baseball sl indurated, warm to touch, no regional adenopathy no streaking".
3/10/21:  - Sore arm at injection site  3/12/21: - 11AM: Welts on bikini area -12:30PM: Welts in bikini area gone -12:45PM: Took a Benadryl  3/13/21: - 4AM: Welts appeared on legs, arms, and buttocks - 11AM: Wake up and welts that were there at 4AM are gone, but there were new welts on the same body parts in  different areas - Throughout the day the welts came and went. I took a Benadryl every 4-6 hours  3/14/21: - Eye was swollen and welts appeared on legs and buttocks
Numbness in arm of injection the size of a golfball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (Numbness in arm of injection the size of a golfball) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DASATINIB MONOHYDRATE (SPRYCEL) and IBUPROFEN for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (Numbness in arm of injection the size of a golfball). At the time of the report, VACCINATION SITE HYPOAESTHESIA (Numbness in arm of injection the size of a golfball) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments. No treatment information was provided.
hives @ inj site, back, legs approx 24-36hr p/vax;responsive to DPH;
Extremely thick vaginal discharge- like a full cup of jelly on Friday. I have never seen that before.     Today it feels like I will be getting a period soon- cramping and uncomfortable.
Therapy non-responder, incorrect dose administered. This case was reported by a nurse and described a 24-year-old female patient who did not respond to immunization to the hepatitis B vaccine recombinant. On 23 October 2003, 25 November 2003, and 06 May 2004 the patient received the first, second and third dose of Engerix-B. The patient inadvertently received the 10 mcg dose for the three doses of the Engerix-B series. The recommended dose of Engerix-B for individuals older than 19 years of age is 20 mcg. On an unspecified date in 2004, at an unspecified time following the third dose of Engerix-B, a hepatitis B surface antibody titer indicated that the patient was "not seroprotected."
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 11 years old child patient and unknown gender. On 14-JUL-2014 the patient was vaccinated with a dose of an improperly stored GARDASIL 120 Y (lot H020901, expiration date 05-JUL-2015) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
Bilateral axillary lymphadenopathy & tenderness, fatigue, headache, body aches x 1 week.
When patient arrived for her second dose of the Novavax primary series on 12/13/22 she reported the following:  Patient reports on 11/23/22 she was at church when she "could see her heart pounding out of her chest." According to her smart watch her heart rate was 230 bpm at one point. At that point her friends had her sit down. She reports that gradually her heart rate decreased throughout the day. She reports "at 10:42 am heart was was 187 and then in the same minute 150."  Patient reported she followed up with her PCP two days later and at that point her heart rate was normal.  Due to this patient report Dr. was contacted. Per Dr. patient was advised not to receive the Novavax vaccine during the appointment on 12/13/22 until she consults with her doctor. Patient verbalized understanding and did not proceed with vaccination.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/27/2022 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, WO BEHAVIORAL DISTURBANCE  HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 10/27/2022 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, WO BEHAVIORAL DISTURBANCE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/27/2022 EPILEPSY, UNSPECIFIED  HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 10/27/2022 EPILEPSY, UNSPECIFIED  ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/27/2022 HYPOGLYCEMIA  HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 10/27/2022 HYPOGLYCEMIA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/27/2022 ALTERED MENTAL STATUS, UNSPECIFIED  HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 10/27/2022 ALTERED MENTAL STATUS, UNSPECIFIED
Nausea, vomiting, fatigue and hot flashes. Started 20 min after injection. Pt received at work and sent home early
2nd dose of vaccine given 4/19/21. Developed URI symptoms (congestion) shortly after which coincided with young kids having URI as well. On or around 5/10/21 he began noticing exertional chest pain and tightness. Symptoms progressed to occurring with less exertion. Admitted 6/2/21 with late-presentation anterior STEMI, underwent emergent angioplasty of multiple lesions.
Possible transverse myelitis developing 2 days after vaccine injection. Death on day 9 after vaccination
Weird; Lethargic; In a daze; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Weird), LETHARGY (Lethargic) and FEELING ABNORMAL (In a daze) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FEELING ABNORMAL (Weird), LETHARGY (Lethargic) and FEELING ABNORMAL (In a daze). At the time of the report, FEELING ABNORMAL (Weird), LETHARGY (Lethargic) and FEELING ABNORMAL (In a daze) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Measles-like rash on chest and abdomen. Suffered fever 4 nights prior that was responsive to Tylenol.
got a Prevnar 20 syringe out of the box and tried to remove the cap on the end of the syringe and the end of the syringe broke off making the syringe unusable; The initial case was missing the following minimum criteria due to no adverse event reported. Upon receipt of follow-up information on 12Sep2023, this case now contains all required information to be considered valid.  This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group.  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht crm197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: GN2778, Expiration Date: Sep2025) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEVICE MALFUNCTION (non-serious), outcome "unknown", described as "got a Prevnar 20 syringe out of the box and tried to remove the cap on the end of the syringe and the end of the syringe broke off making the syringe unusable".  The reporter considered "got a prevnar 20 syringe out of the box and tried to remove the cap on the end of the syringe and the end of the syringe broke off making the syringe unusable" not related to pneumococcal 20-val conj vac (dipht crm197 protein). Causality for "got a prevnar 20 syringe out of the box and tried to remove the cap on the end of the syringe and the end of the syringe broke off making the syringe unusable" was determined associated to device constituent of pneumococcal 20-val conj vac (dipht crm197 protein) (malfunction).  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht crm197 protein)  has been requested and will be submitted if and when received.
(RN) was giving client HPV vaccination in right arm while client was sitting on client table. Client was facing mom, w/ his back to the wall. RN gave shot & went to put band aid on when client started to have shaking, convulsion-or-seizure-like movements and fell backward while still sitting and hit the back of his head on the office wall. Mom stated client's eyes remained open but did not seem alert or aware of what was happening. Mom grabbed patient and helped him lie down on the client table. Client immediately became aware that he might have 'blacked out' or passed out, and then started crying while lying on the client table. RN & mom tried to comfort client & asked how he was feeling. Client stated he felt fine but did have a headache that felt like it was on the top part of his head. Client remained lying and/or sitting on client table for 15 minutes + to make sure he was feeling ok. RN told client's mom that when she felt comfortable, they were ok to leave as long as client was feeling ok. Client walked out of office and building on his own, without assistance.
Narrartive: site soreness x days 1-3; fatigue up to 7 days post 2nd dose.
hearing and vision loss; hearing and vision loss; Information has been received regarding a case in litigation from a lawyer and the pt on 02-OCT-2020, referring to a pt of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about April 2012, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (lot# and route unknown) for long-term prevention of shingles and zoster-related conditions. The pt suffered the following injuries as a result of the zoster vaccine live (ZOSTAVAX) vaccine: hearing and vision loss (deafness and blindness), reported as severe permanent injuries. The outcome of deafness and blindness was reported as not resolved. The causality assessment between deafness and blindness with zoster vaccine live (ZOSTAVAX) was reported as related.  The adverse events deafness and blindness were considered disabled events. Upon internal review, deafness and blindness were determined to be serious adverse events.
pt recvd flu vax 8PM 28OCT93; went to bed 11PM woke @ MN & states felt like throat was closing up; voice became hoarse, heart rate up; called 911, taken to hosp & adm;
fever, chills, loss of appetite. onset about 4 hours after shot.  symptoms dramatically reduced after 36 hours.
This spontaneous report was received from a medical assistant refers to a 63 year old patient. On 17-MAR-2014, the patient was vaccinated accidentally with a dose of VARIVAX (Merck), (lot number and expiry date was not reported), 0.5 ml, subcutaneously instead of ZOSTAVAX. No adverse effect was reported. Additional information is not expected.
pt recv vax 21MAR96 & the next day while mom was bathing pt-pt stopped breathing;CPR was administered & pt responded;pt exp a full sz w/jaw clenching;pt was taken to ER;on arrival in ER pt was in o distress & not exhibiting an sz activity;
Hives on exposed skin only, lasted 1 day. Hydrocortozone cream applied topically.
Pt. seen 8-29-13. Received VVX on 8-31-13. Pt.'s arm at injection site was hot, hard, and swollen from elbow to armpit. Pt. seen at clinic. Dx with cellulitis per Mom and put on abx.
patient had an appointment for booster dose; he did not have his vaccine card with him at the time of the appointment; no vaccine history in EMR; vaccine administered when patient returned to clinic with vaccine card, it was discovered the booster dose was administered too early; it was discovered, also at this time, the patient had two medical records;  second medical record was reviewed; dates of primary series documented;  patient notified; no adverse outcome documented
1. Received shot at 2:30 pm in 1/21. No adverse effects until 4:00 am 1/22. On 1/22 @ 4am began having chills to include uncontrollable shaking like I was really cold, especially in my legs & feet. Fever of 99.7 from 4 am until approximately 2:00 pm on 1/22    2. Also had headache that lasted approximately 2 days.  3. General feeling of being run down for approximately 2 days after receiving shot in 1/21.  *all adverse effects were gone on 1/23 @ 7:00 am.
After  I received my booster, my lymph nodes on the left side (same side I received my injection) were very swollen and remained so for weeks.  Three weeks after receiving it, I had a substantial allergic reaction (hives, oozing, scabbing, swelling) to the same hair dye I?ve been using for a long time.  I can no longer dye my hair, and my lymph nodes swelled up again so much that my ear feels clogged.  My ear is also ringing, and I?m struggling to hear properly.
Fever of 101 degrees, muscle/body aches, migraine-like headache. Felt just like I had the Covid-19 virus again for approximately 24 hours.  I am 5 weeks post infection. I was advised to report symptoms.
Tested positive; Tested positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old male patient received BNT162b2 (BNT162B2), on 21Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 10Nov2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "High Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: PRALUENT; OMEPRAZOLE. Past drug history included: Statins, reaction(s): "Known allergies: Statins", notes: Known allergies: Statins. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 03May2022, outcome "unknown", COVID-19 (medically significant) with onset 03May2022, outcome "not recovered" and all described as "Tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (03May2022) Positive, notes: Tested positive and symptoms returned 8 days after last does. Therapeutic measures were not taken as a result of covid-19.  Clinical information: Other medication in 2 weeks product was Praluent and Omeprazole.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The morning after the shot I began experiencing itchy neck, that turned really red with small rash, more like rough sand paper feeling. The itchiness and redness stayed for the rest of the day and night. The following morning I noticed the rash spreading to my chest. I went to doctor where I was given Zyrtec. This calmed the itchiness and the redness. I didn't feel any itchiness by the following morning. The rash went away as well, but the roughness of my skin is still partially there. I didn't have any other symptoms, or any reaction around the injection site.
Patient received expired dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that the HCP mentioned because of miscommunication as a coworker told that there were some lot number whose expiration dates had been extended, patient received expired dose. The patient received second booster dose. No treatment information was reported.
I had a TIA that lasted about 10 minutes on April 30, 2021, (approx. 3 weeks after the second vaccine).   The back of my head felt 'funny' , not dizzy, but like things getting farther away.  I could talk and raise my arms up, but when I tried to smile, the right side of my mouth drooped, thus I thought I was having a stroke. My partner drove me to the hospital where I was given an MRI, CAT scan in the next hour or so.
After 10 minutes of monitoring he reported experiencing dizziness and sweating. BP 130/60 mmHg, HR 84bpm, 98% SPO2 He denies any prior history of adverse reactions to vaccinations or any history of anaphylaxis to medications or food. Given Gatorade and water, he is sitting comfortably in the recliner. After 20 minutes observation patient reported feeling fine, cleared to be released by NP
<12 hours after receiving the vaccine patient experienced nausea, chills fever to 101., fatigue  1 week after the vaccine started having abdominal pain, alternating constipation and diarrhea.   She persists in having a sore shoulder radiating down her left arm from 12/21-1/18
Within a week and a half post vax, the pt developed a generalized rash. The pt consulted the dermatologist.
Patient states discomfort since injection. Redness is located on the anterior portion of right shoulder. Surrounding skin abnormally hot (right lateral shoulder extending to right upper chest) with region of surrounding erythema, TTP and warmth approximately 6 inch x 8 inch. Treated with doxycycline hydrate 100 mg BID for 10 days.
Vomiting, diahrea and chills 3am Friday 3/19 to roughly 3pm 3/19 with the diahrea continuing for another 12 hours.
Patient received vaccines on 6/26/07-2 days later came in to clinic. (L) arm has 6x8 cm red, slightly edematous, warm area mid deltoid. Patient put on Keflex 250/5 one tsp for 10 days